Colposcopy Market Share

North American Market Forecast

The colposcopy market in North America is set to be the largest with a share of almost 32% in 2037. The growing prevalence of cervical cancer will augment the market widening. Colposcopy allows for a closer examination of the cervix to assess the extent and severity of any abnormality. According to the American Cancer Society, 13,960 women in the United States will be diagnosed with cervical cancer in 2023, with 4,310 dying from it. Moreover, in the United States, every year around 13,000 cases of cervical cancer have been reported and nearly 4000 women die of this disease.

APAC Market Analysis

The Asia Pacific colposcopy market is estimated to register close to 27% by 2037. The rising initiatives by the government to focus on women’s health will drive market size in the region. Under the Ayushman Bharat Health and Wellness Centers, the government set up around 77000 health and wellness centers all across the country. This center focuses on screening preventable and non-communicable diseases among women. Moreover, in the fiscal year 20-21, USD 270 million has been set out under the National Health Mission for various Maternal Health Initiatives. Government policies increase public awareness campaigns to educate women about the importance of cervical cancer screening, including the use of colposcopy.